HNN3.0
Register
Register
Register

Project cooperationUpdated on 19 December 2025

Organs-on-Chip and Microphysiological Systems

Funding Manager Health at imec

Leuven, Belgium

About

Technology blocks like microfluidics, high-density electrodes, biosensors, lens-free imaging and data analytics allow for highly detailed single-cell prediction of human responses. Currently imec is developing MPS systems for the blood-brain-barrier, brain, heart, gut and lung.

Imec is actively looking for partners to further finetune their organ-on-chip models towards specific applications. Please see below, the activities imec could cover for the selected Health 2026 call topics.

  • HORIZON-HLTH-2026-01-TOOL-03: We can contribute by developing innovative MPS models.

  • HORIZON-HLTH-2026-01-TOOL-06 - We can support this CSA by offering our expertise on end-user needs and requirements to facilitate the industrial adoption of MPS.

  • HORIZON-HLTH-2026-01-DISEASE-11 - We can contribute by developing MPS models of CVD to study sex differences.

Topic

  • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-11: Understanding of sex and/or gender-specific mechanisms of cardiovascular diseases: determinants, risk factors and pathways
  • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
  • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-06: Support to European Research Area (ERA) action on accelerating New Approach Methodologies (NAMs) to advance biomedical research and testing of medicinal products and medical devices

Type

  • Partner seeks Consortium/Coordinator

Organisation

imec

R&D Institution

Leuven, Belgium

Similar opportunities

  • Project cooperation

    Research on hepato-gastrointestinal disorders

    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-15: Scaling up innovation in cardiovascular health
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
    • DESTINATION 1: HORIZON-HLTH-2026-01-STAYHLTH-02: Behavioural interventions as primary prevention for Non-Communicable Diseases (NCDs) among young people
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-06: Support to European Research Area (ERA) action on accelerating New Approach Methodologies (NAMs) to advance biomedical research and testing of medicinal products and medical devices

    Carlos Lopez-Gomez

    Tenure track researcher at Biomedical Research Institute of Málaga

    Málaga, Spain

  • Project cooperation

    Clinical Training & Validation Partner for Horizon Health Consortia

    • DESTINATION 4: HORIZON-HLTH-2026-01-CARE-03: Identifying and addressing low-value care in health and care systems
    • DESTINATION 6: HORIZON-HLTH-2026-01-IND-03: Regulatory science to support translational development of patient-centred health technologies
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-07: Establishing a European network of Centres of Excellence (CoEs) for Advanced Therapies Medicinal Products (ATMPs)
    • DESTINATION 4: HORIZON-HLTH-2026-01-CARE-01: Public procurement of innovative solutions for improving citizens' access to healthcare through integrated or personalised approaches

    Luca Takács

    Founder and CEO at LNP Academy

    Budapest, Hungary

  • Project cooperation

    EXAscale Performance SYStems for AI acceleration

    • Partner seeks Consortium/Coordinator
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-15: Scaling up innovation in cardiovascular health
    • DESTINATION 2: HORIZON-HLTH-2026-01-ENVHLTH-04: Towards climate resilient, prepared and carbon neutral populations and healthcare systems
    • DESTINATION 6: HORIZON-HLTH-2026-01-IND-03: Regulatory science to support translational development of patient-centred health technologies
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-11: Understanding of sex and/or gender-specific mechanisms of cardiovascular diseases: determinants, risk factors and pathways

    Dimitris Theodoropoulos

    Project management support at Exascale Peformance Systems - EXAPSYS

    Chania, Crete, Greece